MODULATION OF LUNG ENDOTHELIAL PERMEABILITY BY AUTACOIDS
Autacoids 对肺内皮细胞通透性的调节
基本信息
- 批准号:3357789
- 负责人:
- 金额:$ 11.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1989
- 资助国家:美国
- 起止时间:1989-07-10 至 1993-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The measurement of blood-tissue permeability in the lung has
proven to be extremely difficult. We have developed a new in
vitro method to measure the permeability of cultured endothelial
cell layers from pulmonary arteries, veins, and microvessels. The
method offers a fresh approach and overcomes many of the
difficulties of whole animal methods used to study the increased
permeability edema often characteristic of the adult respiratory
distress syndrome. Blood-tissue permeability increases are
difficult to prove in animal models of increased permeability
edema. For example, investigators have such the sheep lung-
lymph preparation and stimuli such as histamine, endotoxin, and
thrombin as models of lung injury similar to increased
permeability edema. However, blood-tissue permeability changes
cannot be clearly identified in these animal models, since the lung
injury is accompanied by increased intravascular pressures which
could also account for the observed increased flux of fluid and
solutes. In vitro methods will help identify specific permeability
changes induced by agents producing lung injury in animals. Using
recent advances in cell culture methods, the permeability
characteristics of the endothelial component of the blood-tissue
barrier have begun to be investigated. However, these results are
being questioned, since these in vitro methods find permeabilities
1000 times greater than in vivo estimates.
In preliminary experiments, our in vitro method finds endothelial
permeabilities similar to in vivo estimates. This new method
utilizes a monolayer of endothelial cells cultured on microcarrier
beads as a selective barrier to control the passage of molecular
species from the mobile phase of a liquid chromatography column
to the stationary phase within the cell covered microcarrier
beads. We propose to use this method to clarify the role of the
endothelial barrier in blood-tissue permeability and, in addition,
measure how the permeability properties are altered by naturally
occurring stimuli, i.e. autacoids. This proposal has three main
aims: 1) to measure the in vitro intercellular permeability of the
pulmonary endothelial cell layer to mannitol and polyethylene
glycol; 2) to characterize the permeability of the pulmonary
endothelial cell layer with respect to tracer size and charge; and
3) to test the hypothesis that autacoids alter pulmonary
endothelial cell permeability by measuring permeability changes
produced by three autacoids, which have been described as
reversible modulators of blood-tissue permeability in the
lung: norepinephrine, thrombin and histamine.
肺中血液组织渗透性的测量具有
被证明是非常困难的。 我们开发了一种新的
体外测定培养内皮细胞通透性的方法
来自肺动脉、静脉和微血管的细胞层。 的
方法提供了一种新的方法,并克服了许多
用于研究增加的整个动物方法的困难
渗透性水肿通常是成人呼吸道疾病的特征,
痛苦综合症 血液组织渗透性增加
难以在渗透性增加的动物模型中证明
水肿 例如,研究人员有这样的羊肺-
淋巴制剂和刺激物如组胺、内毒素,
凝血酶作为肺损伤模型的相似性增加
渗透性水肿 然而,血液组织渗透性的变化
在这些动物模型中不能清楚地识别,因为肺
损伤伴随血管内压力增加,
也可以解释观察到的流体流量增加,
溶质。 体外方法将有助于确定特定的渗透性
在动物中产生肺损伤的药剂引起的变化。 使用
细胞培养方法的最新进展,
血液组织内皮成分的特征
障碍已经开始调查。 然而,这些结果是
受到质疑,因为这些体外方法发现渗透性
比体内估计值高1000倍。
在初步实验中,我们的体外方法发现内皮细胞
渗透性与体内估计相似。 这种新方法
利用在微载体上培养的单层内皮细胞
微珠作为选择性屏障来控制分子通过
来自液相色谱柱的移动的相的物质
到细胞覆盖的微载体内的固定相
珠 我们建议使用这种方法来阐明
血液组织渗透性的内皮屏障,此外,
测量渗透性如何被自然改变
发生的刺激,即autacoids。 该提案有三个主要内容
目的:1)测定体外培养的人脐静脉内皮细胞的细胞间通透性,
肺内皮细胞层对甘露醇和聚乙烯
乙二醇; 2)表征肺的渗透性
内皮细胞层相对于示踪剂大小和电荷的变化;和
3)为了检验自伤药改变肺功能的假设,
通过测量渗透性变化的内皮细胞渗透性
由三种autacoids产生,它们被描述为
血液组织通透性的可逆调节剂,
肺:去甲肾上腺素、凝血酶和组胺。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Frederick R Haselton其他文献
Frederick R Haselton的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Frederick R Haselton', 18)}}的其他基金
Urine TB diagnostic by amplicon reconstruction for PCR detection of DNA fragments
通过扩增子重建进行 DNA 片段 PCR 检测诊断尿结核
- 批准号:
10385847 - 财政年份:2021
- 资助金额:
$ 11.01万 - 项目类别:
Point-of-Care RT-PCR System to Inform COVID-19 and Respiratory Illness Decisions
护理点 RT-PCR 系统可为 COVID-19 和呼吸道疾病决策提供信息
- 批准号:
10688237 - 财政年份:2020
- 资助金额:
$ 11.01万 - 项目类别:
Retinal Imaging of Prognostic Indicators of Atherosclerosis
动脉粥样硬化预后指标的视网膜成像
- 批准号:
7573116 - 财政年份:2009
- 资助金额:
$ 11.01万 - 项目类别:
Retinal Imaging of Prognostic Indicators of Atherosclerosis
动脉粥样硬化预后指标的视网膜成像
- 批准号:
7787531 - 财政年份:2009
- 资助金额:
$ 11.01万 - 项目类别:
Development of DNA Logic Operations for Viral Diagnostics
用于病毒诊断的 DNA 逻辑运算的开发
- 批准号:
7573152 - 财政年份:2009
- 资助金额:
$ 11.01万 - 项目类别:
Development of DNA Logic Operations for Viral Diagnostics
用于病毒诊断的 DNA 逻辑运算的开发
- 批准号:
7797468 - 财政年份:2009
- 资助金额:
$ 11.01万 - 项目类别:
Multi-spectral quantum dot-based retinal imaging of molecular expression in vivo
基于多光谱量子点的体内分子表达视网膜成像
- 批准号:
7351806 - 财政年份:2007
- 资助金额:
$ 11.01万 - 项目类别:
Multi-spectral quantum dot-based retinal imaging of molecular expression in vivo
基于多光谱量子点的体内分子表达视网膜成像
- 批准号:
7583895 - 财政年份:2007
- 资助金额:
$ 11.01万 - 项目类别:
Multi-spectral quantum dot-based retinal imaging of molecular expression in vivo
基于多光谱量子点的体内分子表达视网膜成像
- 批准号:
7192344 - 财政年份:2007
- 资助金额:
$ 11.01万 - 项目类别:
Lagrangian detection of biomolecular interactions
生物分子相互作用的拉格朗日检测
- 批准号:
6763620 - 财政年份:2004
- 资助金额:
$ 11.01万 - 项目类别:
相似海外基金
A cluster randomized controlled trial to evaluate pharmacy-based health promotion program to improve blood pressure control in Bangladesh, India and Pakistan
一项整群随机对照试验,旨在评估孟加拉国、印度和巴基斯坦基于药房的健康促进计划,以改善血压控制
- 批准号:
23K24566 - 财政年份:2024
- 资助金额:
$ 11.01万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Defining a new mechanism of blood pressure regulation and its role during sepsis
定义血压调节的新机制及其在脓毒症期间的作用
- 批准号:
MR/Y011805/1 - 财政年份:2024
- 资助金额:
$ 11.01万 - 项目类别:
Research Grant
Blood pressure trajectory of inpatient rehabilitation stroke patients from the Determining Optimal Post-Stroke Exercise (DOSE) trial over the first 12-months post-stroke
通过确定最佳中风后运动 (DOSE) 试验得出的中风住院康复患者在中风后 12 个月内的血压轨迹
- 批准号:
493123 - 财政年份:2023
- 资助金额:
$ 11.01万 - 项目类别:
Cuffless models to infer blood pressure from bioimpedance
无袖带模型可根据生物阻抗推断血压
- 批准号:
2319920 - 财政年份:2023
- 资助金额:
$ 11.01万 - 项目类别:
Standard Grant
AirPressureNYC: Reducing AIR pollution to lower blood PRESSURE among New York City public housing residents
AirPressureNYC:减少空气污染以降低纽约市公共住房居民的血压
- 批准号:
10638946 - 财政年份:2023
- 资助金额:
$ 11.01万 - 项目类别:
Central Nervous System Reprogramming of the Control of Blood Pressure Induced by Early Life Stress
早期生活压力引起的血压控制的中枢神经系统重新编程
- 批准号:
10555126 - 财政年份:2023
- 资助金额:
$ 11.01万 - 项目类别:
I-Corps: Blood Pressure Monitoring by a Miniaturized Cuffless Sensor
I-Corps:通过小型无袖带传感器进行血压监测
- 批准号:
2332674 - 财政年份:2023
- 资助金额:
$ 11.01万 - 项目类别:
Standard Grant
Machine Learning Enabled Non-contact Sensing Platform for Blood Pressure and Glucose Prediction
用于血压和血糖预测的机器学习非接触式传感平台
- 批准号:
23K11341 - 财政年份:2023
- 资助金额:
$ 11.01万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Blood pressure imaging by contrast enhanced active Doppler ultrasound
通过对比增强主动多普勒超声进行血压成像
- 批准号:
23K18557 - 财政年份:2023
- 资助金额:
$ 11.01万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
The mechanism of non-dipper blood pressure induced by intermittent hypoxia during sleep
睡眠间歇性缺氧引起非杓型血压的机制
- 批准号:
23K06336 - 财政年份:2023
- 资助金额:
$ 11.01万 - 项目类别:
Grant-in-Aid for Scientific Research (C)